Entero Therapeutics announces 1-for-3 reverse stock split to regain Nasdaq compliance

GridAI Technologies Corp.

Reverse stock split at ratio 1-for-3 effective 12:01 a.m. ET on August 18, 2025.
Outstanding shares reduce from ~4.77 million to ~1.59 million; no fractional shares issued.
Split intended to raise bid price above $1.00 to satisfy Nasdaq Listing Rule 5550(a)(2).
Trading symbol remains ENTO; new CUSIP is 33749P507.
Interim CEO Richard Paolone states split is necessary to maintain Nasdaq listing.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.